ATE95195T1 - Mikroproteine, verfahren zur herstellung derselben und anwendung dieser mikroproteine als arzneimittel. - Google Patents

Mikroproteine, verfahren zur herstellung derselben und anwendung dieser mikroproteine als arzneimittel.

Info

Publication number
ATE95195T1
ATE95195T1 AT90401432T AT90401432T ATE95195T1 AT E95195 T1 ATE95195 T1 AT E95195T1 AT 90401432 T AT90401432 T AT 90401432T AT 90401432 T AT90401432 T AT 90401432T AT E95195 T1 ATE95195 T1 AT E95195T1
Authority
AT
Austria
Prior art keywords
microproteins
residue
norleucine
pharmaceuticals
manufacture
Prior art date
Application number
AT90401432T
Other languages
English (en)
Inventor
Bertrand Castro
Anne Favel
Dung Le-Nguyen
Maria-Antonia Previero
Original Assignee
Roussel Uclaf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf filed Critical Roussel Uclaf
Application granted granted Critical
Publication of ATE95195T1 publication Critical patent/ATE95195T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dermatology (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT90401432T 1989-05-31 1990-05-30 Mikroproteine, verfahren zur herstellung derselben und anwendung dieser mikroproteine als arzneimittel. ATE95195T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8907155A FR2647677B1 (fr) 1989-05-31 1989-05-31 Nouvelles micro-proteines, procede de preparation et application a titre de medicaments de ces nouvelles micro-proteines
EP90401432A EP0401109B1 (de) 1989-05-31 1990-05-30 Mikroproteine, Verfahren zur Herstellung derselben und Anwendung dieser Mikroproteine als Arzneimittel

Publications (1)

Publication Number Publication Date
ATE95195T1 true ATE95195T1 (de) 1993-10-15

Family

ID=9382205

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90401432T ATE95195T1 (de) 1989-05-31 1990-05-30 Mikroproteine, verfahren zur herstellung derselben und anwendung dieser mikroproteine als arzneimittel.

Country Status (8)

Country Link
US (1) US5089474A (de)
EP (1) EP0401109B1 (de)
JP (1) JPH0368599A (de)
AT (1) ATE95195T1 (de)
CA (1) CA2017803A1 (de)
DE (1) DE69003595T2 (de)
ES (1) ES2060100T3 (de)
FR (1) FR2647677B1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5432155A (en) * 1993-06-29 1995-07-11 The Salk Institute For Biological Studies Conotoxins I
DE4342092B4 (de) * 1993-12-09 2007-01-11 Zentaris Gmbh Langwirkende Injektionssuspension und Verfahren zur Herstellung
RU2151611C1 (ru) * 1999-06-18 2000-06-27 Общество с ограниченной ответственностью НАУЧНО-ПРОИЗВОДСТВЕННОЕ ПРЕДПРИЯТИЕ "МЕДБИОФАРМ" Средство для регулирования йодного обмена или профилактики йоддефицитных состояний
US7282227B2 (en) * 2002-08-09 2007-10-16 Kentara Research Llc Method for treating hepatitis C with evaporate of Ecballium elaterium extract
US7297350B2 (en) * 2002-08-09 2007-11-20 Kentara Research Llc Evaporate of Ecbalium elaterium fruit extract for treating viral symptoms
AU2005287557B2 (en) * 2004-09-21 2011-10-13 Biontech Ag Use of microproteins as tryptase inhibitors
US20090099031A1 (en) * 2005-09-27 2009-04-16 Stemmer Willem P Genetic package and uses thereof
WO2007038619A2 (en) * 2005-09-27 2007-04-05 Amunix, Inc. Proteinaceous pharmaceuticals and uses thereof
US7855279B2 (en) * 2005-09-27 2010-12-21 Amunix Operating, Inc. Unstructured recombinant polymers and uses thereof
US7846445B2 (en) 2005-09-27 2010-12-07 Amunix Operating, Inc. Methods for production of unstructured recombinant polymers and uses thereof
EP1996220B2 (de) * 2006-03-06 2023-08-16 Amunix Operating Inc. Unstrukturierte rekombinante polymere und verwendungen davon
US8933197B2 (en) * 2007-08-15 2015-01-13 Amunix Operating Inc. Compositions comprising modified biologically active polypeptides
BR122021021381B1 (pt) 2009-02-03 2023-05-16 Amunix Pharmaceuticals, Inc Método de aprimoramento de uma propriedade de uma proteína biologicamente ativa
JP2013502458A (ja) 2009-08-24 2013-01-24 アムニクス オペレーティング インコーポレイテッド 凝固第ｖｉｉ因子組成物ならびにそれを製造および使用する方法
JP6383666B2 (ja) 2012-02-15 2018-08-29 バイオベラティブ セラピューティクス インコーポレイテッド 組換え第ｖｉｉｉ因子タンパク質
BR112014020694A2 (pt) 2012-02-15 2018-05-08 Amunix Operating Inc. proteína de fusão do fator viii compreendendo polipeptídeo do fator viii fusionado a polipeptí-deo recombinante estendido (xten) e seu método de fabricação, ácido nucleico, vetores, célula hospedeira, bem como composição farmacêutica e seu uso no tratamento de coagulopatia, episódio de hemorragia e hemofilia a
WO2015023891A2 (en) 2013-08-14 2015-02-19 Biogen Idec Ma Inc. Factor viii-xten fusions and uses thereof
EA201890423A1 (ru) 2015-08-03 2018-07-31 Биовератив Терапьютикс Инк. Слитые белки фактора ix, способы их получения и применения
KR20260008164A (ko) 2016-12-02 2026-01-15 바이오버라티브 테라퓨틱스 인크. 키메라 응고 인자를 사용해 혈우병성 관절증을 치료하는 방법
MA52630B1 (fr) 2018-05-18 2025-07-31 Bioverativ Therapeutics Inc. Procédés de traitement de l'hémophilie a

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3230275A1 (de) * 1982-08-14 1984-02-16 Bayer Ag, 5090 Leverkusen Elastaseinhibitoren, verfahren zu ihrer herstellung sowie diese enthaltende arzneimittel
DE3587526T3 (de) * 1984-12-06 2002-08-08 Amgen Inc.(N.D.Ges D. Staates Delaware), Thousand Oaks Serinproteaseinhibitoren und isolierungsverfahren dazu.
US4829052A (en) * 1986-06-11 1989-05-09 Monsanto Company Serine protease inhibitors

Also Published As

Publication number Publication date
ES2060100T3 (es) 1994-11-16
EP0401109A1 (de) 1990-12-05
DE69003595T2 (de) 1994-02-17
JPH0368599A (ja) 1991-03-25
US5089474A (en) 1992-02-18
FR2647677A1 (fr) 1990-12-07
EP0401109B1 (de) 1993-09-29
CA2017803A1 (fr) 1990-11-30
FR2647677B1 (fr) 1991-09-27
DE69003595D1 (de) 1993-11-04

Similar Documents

Publication Publication Date Title
ATE95195T1 (de) Mikroproteine, verfahren zur herstellung derselben und anwendung dieser mikroproteine als arzneimittel.
ATE196650T1 (de) Stabile bakterizide proteine, welche die permeabilität erhöhen und pharmazeutische zusammensetzungen, diese enthaltend
HU906177D0 (en) Process for the production of peptide derivatives and medical and diagnostical preparations containing such derivatives
FI910286A0 (fi) Analoger av humant insulin och preparat innehaollande dessa.
HUP0001293A1 (hu) Heterociklusos vegyületek és ezeket tartalmazó gyógyászati készítmények béta-amiloid-peptidek gátlására
FR2695317B1 (fr) Composition apte à stimuler la sécrétion d'insuline destinée au traitement du diabète non insulino-dépendant.
ATE121755T1 (de) Deletionsanaloga von magaininpeptiden.
AU1094892A (en) Improved activation of recombinant proteins
DE69129899D1 (de) Verfahren zur Herstellung von D-Alpha-Aminosäuren
ATE10626T1 (de) N-substituierte omega-(2-oxo-imidazolin-1-yl)alkans[uren, deren salze und ester, verfahren zu deren herstellung und diese aktiven substanzen enthaltende pharmazeutische zubereitungen.
ATE213499T1 (de) Peptidanaloge des menschlichen, basischen myelinproteins mit substitution an position 91 zur behandlung der multiplen sklerose
AU5372590A (en) New carboxamide group-containing (meth)acrylic acid esters, adhesive components, containing these compounds, for the treatment of collagen-containing materials and preparation and use of these adhesive components
KR910002899A (ko) 혈조절 펩타이드
EP0329008A3 (de) Cephalosporinderivative und Verfahren zu ihrer Herstellung
CA2096532A1 (en) New human recombinant gamma-interferon
ATE138936T1 (de) Neue peptidderivate, verfahren zu deren herstellung und deren anwendung als heilmittel
HUP9602024A2 (hu) Aminosavtartalmú, külsőlegesen használható, gyógyhatású készítmény
IE881710L (en) (2-Cyano-2-oximinoacetyl)-amino acid derivatives
ATE25708T1 (de) Biologisch aktive konjugate, ihre herstellung und ihre anwendung.
ATE141615T1 (de) Neue peptid-derivate mit bradikyninantagonischer wirkung, verfahren zur deren herstellung und pharmazeutische zubereitungen die sie enthalten
DE69315730D1 (de) Verfahren zur Herstellung von Peptiden und neue Zwischenverbindungen dazu
EP0351676A3 (de) Benzothiazolone
DE69007010D1 (de) Nichtfestes Augenarzneimittel und Verfahren zur Herstellung dieses Arzneimittels.
EP0373461A3 (de) Benzazole
DK0487410T3 (da) Endothelinantagonister.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee